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expression: a Gynaecological Oncology
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Background: Lobular endocervical glandular hyperplasia (LEGH) is a rare lesion of the uterine cervix. It has been proposed that
LEGH may represent a precursor lesion to a group of mucinous adenocarcinoma with gastric phenotype (GA) that is independent
of high-risk human papillomavirus (H-HPV) infection. Carbonic anhydrase-IX (CA-IX) is highly expressed in conventional glandular
lesions (CGLs). However, expression of CA-IX in LEGH or GA has not been studied.
Methods: In all, 12 CGLs, 7 LEGHs, 6 LEGHs with coexisting adenocarcinoma in situ (AIS, 3) and GA (3) were identified from
Japanese women with a cytological diagnosis of atypical glandular cells of undetermined significance. Immunostaining was used
to detect CA-IX and p16INK4a (hereafter termed p16) protein expression in the tissues and CA-IX protein expression in the
Papanicolaou smears (PSs). Polymerase chain reaction was used to detect H-HPV DNA in liquid-based cytology.
Results: Out of 12 (83%) CGLs, 10 were positive with H-HPV and high levels of CA-IX expression were seen in all (100%) cases. P16
protein expression was observed in 11 out of 12 (92%) cases. None of the LEGHs, LEGHs with AIS or GA were positive for H-HPV
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and only 8 out of 13 (62%) showed focal weak (1þ ) p16 expression. In contrast, all cases (100%) exhibited strong CA-IX protein
expression.
Conclusion: Our study suggests that there are different molecular mechanisms of carcinogenesis resulting in CGLs vs LEGHs
associated with AIS or GA. There is also a possible link between LEGHs and GAs. Furthermore, CA-IX expression may serve as a
useful biomarker for the detection of GAs in the absence of H-HPV infection.
Widespread cervical screening in developed countries has led to a
dramatic decline in the incidence of cervical squamous cell
carcinoma; however, the rate of endocervical adenocarcinomas
remains the same or is on the rise (Smith et al, 2000; Bray et al,
2005). The false negative rate in the cytological screening for
cervical adenocarcinomas overall is higher than that for squamous
lesions (Makino et al, 1995). The overlapping cytological features
between reactive and neoplastic glandular cells may have an
important role in the underdiagnosis of glandular neoplasia, and
this is particularly true in the diagnosis of early or well-
differentiated adenocarcinoma, such as minimal deviation adeno-
carcinoma (MDA). The cervical adenocarcinomas encompass a
heterogeneous group of tumours, including mucinous and non-
mucinous types. The mucinous type includes the prototypical
endocervical adenocarcinoma of usual type and other subtypes,
such as intestinal, villoglandular and MDA. The non-mucinous
tumours include endometrioid, clear-cell, serous and mesonephric
types. Recently, a subtype of mucinous adenocarcinoma expressing
gastric phenotype (GA) has also been described. To date, this type
of adenocarcinoma has been primarily identified in the Japanese
population and the term ‘gastric-type endocervical adenocarci-
noma’ has been used in the literature (Kojima et al, 2007; Kusanagi
et al, 2010; Park et al, 2011). The tumour shows voluminous
amounts of gastric-type mucin within the cytoplasm, giving a pale
eosinophilic appearance of neoplastic cells. The cytological atypia
can be mild to severe. It has been postulated that MDA is an
extremely well-differentiated form of the broader category of GA
(Ishii et al, 1998; Mikami et al, 2004). Minimal deviation
adenocarcinoma of the cervix is a neoplasm distinguished by its
deceptively bland histological features. Although the lesion only
accounts for 1 to 3% of all endocervical adenocarcinomas, the
prognosis of the advanced-stage disease is poor. In fact, delayed
diagnosis occurs in most of the cases (Gilks et al, 1989). In 1999,
Nucci and co-workers described a new pseudoneoplastic glandular
lesion of the cervix, termed lobular endocervical glandular
hyperplasia (LEGH) and considered this as a hyperplastic
glandular lesion, sharing similar clinical and histological features
with MDA. The importance of the separation between LEGH and
MDA has been emphasised in the past. However, in recent years it
has been speculated that LEGH may represent the precursor of GA,
incorporating MDA as its well-differentiated form based on the
following observations: (1) up to 19% of cases of LEGH showed
coexisting GA (Nara et al, 2007); (2) both LEGH and GA share a
similar immunophenotype of gastric pyloric glands (Mikami et al,
2001, 2004); and (3) it has been postulated that MDA with gastric
phenotype may represent an extremely well-differentiated form of
GA. Lastly, one recent study has shown that copy number gains of
chromosome 3q and loss of 1p in 3 of 14 (21%) LEGHs were also
common to MDA and mucinous adenocarcinoma (Kawauchi et al,
2008). This observation is consistent with a possible molecular–
genetic link between LEGH and GA/MDA. Therefore, it appears
that separating LEGHs from other mimics of benign cervical
glandular lesions is as important as correctly diagnosing GAs/
MDAs.
Infection with oncogenic high-risk human papillomavirus (H-
HPV) type(s) is widely accepted to be an important aetiological
factor for cervical cancer (zur Hausen, 2002; Bosch et al, 2008).
High-risk human papillomavirus has been detected in 97–99% of
cervical cancers (Walboomers et al, 1999; Liao et al, 2009) and 83–
100% of adenocarcinomas and their precursor glandular lesions
(Pirog et al, 2000; Liao et al, 2009). P16INK4a (hereafter termed
p16) is a tumour suppressor gene that has a central role in the
regulation of the cell cycle. It has been shown that strong p16
expression in cervical carcinomas is associated with H-HPV
infection. Thus, p16 has been commonly accepted as a surrogate
biomarker for diagnosing cervical dysplasia/neoplasia associated
with H-HPV infection (Klaes et al., 2001; Negri et al, 2003).
However, in recent years, certain subsets of cervical adenocarci-
nomas have been identified, namely MDA and mucinous GA,
clear-cell carcinoma and mesonephric carcinoma that are not
associated with H-HPV infection (Pirog et al, 2000; Kusanagi et al,
2010; Park et al, 2011).
In the 1990s, the antigen MN was identified (Za´vada et al,
1993). MN is a glycoprotein, and was found to be a member of the
carbonic anhydrase (CA) gene family, designated CA-IX (Opavsky´
et al, 1996). Carbonic anhydrase-IX is a biomarker of several
human tumours, including carcinomas of the cervix and kidney
(Liao et al, 1994, 1997). Carbonic anhydrase-IX expression in
cancerous tissues, and its absence in normal counterparts, has led
to the speculation that it has a role in carcinogenesis (Wykoff et al
2000; Ivanov et al, 2001). Its expression is controlled by the
transcription factor, hypoxia-inducible factor-1, and is upregulated
in hypoxic regions of tumour tissues (Wykoff et al, 2000; Ivanov
et al, 2001; Swietach et al, 2007).
In a survey of benign and neoplastic cervical tissues and PSs,
it was observed that high levels of CA-IX were expressed by
virtually all atypical glandular cells associated with adenocarci-
noma in situ (AIS) and adenocarcinoma, but in the benign cervix
CA-IX protein was either undetected or present in low levels,
restricted to a few endocervical glandular cells and reserve cells.
This suggested that high levels of CA-IX expression in cervical
glandular cells may serve as a useful biomarker for diagnosing
conventional glandular lesions (CGLs) of the cervix, including AIS
and adenocarcinoma (Liao et al, 1994, 2009; Liao and Stanbridge,
1996, 2000). However, CA-IX expression in special subtypes of
cervical lesions, such as LEGH and GA/MDA, has not been
reported.
In 1998, the Gynaecologic Oncology Group (GOG), an
international multi-institutional clinical trials group supported
by the US National Cancer Institute, conducted a study of
women with a cytological diagnosis of atypical glandular cells of
undetermined significance (AGC). A total of 25 Institutions in the
United States (Liao et al, 2009) and 11 institutions in Japan
participated in the trial (Liao et al, 2010). In the Japanese cohort,
H-HPV had a sensitivity of 53% in CGLs and an overall specificity
of 86%, whereas CA-IX had a sensitivity of 100% in CGLs
and an overall specificity of 50% (Liao et al, 2010). In a
retrospective histological review of all cases retrieved from the
Japanese cohorts, there were 13 cases of LEGH identified. Among
these LEGH cases, three coexisted with AIS and three with GA.
All of these three GAs were well differentiated with coexisting
morphological spectrum of MDA. Here we report the results of
H-HPV testing, using polymerase chain reaction (PCR), and p16
and CA-IX expression, using immunohistochemical staining, in
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the Japanese cases of LEGH and LEGH with coexisting AIS or
GA. The objective of this study was to determine the degree of
association between H-HPV infection, p16 and CA-IX expression,
in LEGH, and in cases of LEGH with coexisting AIS and GA,
and to ascertain their relative diagnostic utility. For comparative
purposes, we included cases of CGLs from the same Japanese
cohort.
MATERIALS AND METHODS
The criteria of AGC diagnosis for patient enrolment were based on
the 1991 TBS classification (Kurman and Solomon, 1994) and
conventional PSs were used. The protocol used in this study was
approved by the National Cancer Institute, Division of Cancer
Prevention and the GOG Human Research Committee, and
annually by the Institutional Review Board (IRB) at each of the
participating institutions.
Patient selection and tissue samples. Women over the age of 18
years, with a referring diagnosis of AGC and who were expected,
on a clinical basis, to undergo complete histological evaluation of
the cervical transformation zone, either with LEEP and/or cold
knife cone or hysterectomy within 6 months of the initial
cytological diagnosis, were enrolled in the study. Before enrollment
all patients signed an informed consent form. Sample collection,
patient eligibility, clinical management and histological evaluation
have been described elsewhere (Liao et al, 2009, 2010). Briefly, all
H&E-stained histological slides of the most abnormal lesions from
each diagnostic procedure were reviewed centrally by the teams of
two gynaecological pathologists from the GOG Pathology
Committee who reached a consensus diagnosis. The diagnosis of
each case was entered to the Statistical Data Base. Retrospective
review of the histology of all H-HPV tested cases enrolled in the
Japanese study population was conducted by one of the authors
(SYL). The diagnosis of LEGH and LEGH with atypical features
was established based on the criteria proposed by Nucci et al
(1999) and Mikami et al (2004). Briefly, LEGH without atypia was
defined as follows: (1) proliferation of small glands in a lobular
manner; (2) abundant intracytoplasmic mucin giving a pale
eosinophic appearance of glandular cells; (3) basally located round
nuclei without anaplasia; and (4) absence of distinct evidence of
destructive stroma (Figure 1A). Lobular endocervical glandular
hyperplasia with atypical features was defined as follows:
(1) nuclear enlargement, with irregularity and conspicuous
nucleoli; (2) loss of polarity and papillary growth; and (3) the
presence mitotic figures and apoptotic bodies and/or nuclear debris
in the lumen (Figures 1C, D and 3A, D, G). The novel criteria
outlined by Kojima et al (2007) were used to define the diagnosis of
GA. Those criteria are: (1) clear or pale eosinophilic cytoplasm;
(2) voluminous cytoplasm; and (3) distinct cell borders (Figures 1F
and 2D). For conventional endocervical adenocarcinoma, AIS, the
World Health Organisation (WHO) classification (Tavassoli and
Devilee, 2003) was used. To be consistent with our previous reports
(Liao et al, 2009, 2010), in this study we use the term CGL to apply
to conventional endocervical adenocarcinoma and AIS without
coexisting LEGH, and GA to apply to cases with the morphological
spectrum of MDA but with gastric phenotype, associated with
LEGH. There were 84 cases with known H-HPV data enrolled in
the Japanese cohort, and among these, 12 CGLs, 7 LEGHs and 6
LEGHs with coexisting AIS or GA were identified. All of the cases
of CGL, LEGH, LEGH with AIS or GA were independently
reviewed by the second gynaecological pathologist (WHR) and
consensus was reached in all cases. All 84 cases with known
H-HPV data were screened for p16 and CA-IX expression in the
tissue sections of the cervix and CA-IX expression in the PSs.
Among these, 27 cases with benign cervix were included in the
study to serve as the negative control group.
Immunohistochemistry
Detection of CA-IX in a conventional study PS. Immunodetection
of CA-IX was performed on conventional study PSs using the anti
CA-IX mouse monoclonal antibody, M75, as described previously
(Liao et al, 1994). Specific immunostaining was defined by the
presence of a brown reaction product along the plasma membrane
under  40 magnification. Faint staining of the cytoplasm was
considered negative. Immunostaining was scored as positive or
negative as described previously (Liao and Stanbridge, 1996; Liao
et al, 2010). Briefly, the positive reaction was defined as when any
immunoreactivity was identified in atypical cells or strong dark
brown membranous positivity was observed in the normal looking
endocervical cells. No immunoreactivity or faint staining was
considered as negative.
Detection of CA-IX and p16 in tissue sections. Carbonic
anhydrase-IX and p16 immunostaining was performed on 5-mm-
thick sections of formalin-fixed paraffin-embedded tissues, using
CA-IX and p16 antibodies (clone G175-405; BD Pharmingen,
Erembodegem-Aalst, Belgium). The Ventana amplification ultra-
view DAB detection kit in a Ventana BenchMark XT processor
(Ventnana, Tucson, AZ, USA) was used for detecting CA-IX and
p16 protein expression. The appropriate antigen retrieval metho-
dology was used according to the manufacturer’s recommendation.
The dilutions of antibodies used were as follows: CA-IX (1 : 5000)
and p16 (1 : 25). The extent and the intensity of immunostaining
were evaluated independently by two pathologists (SYL and WHR)
and consensus was reached in all cases. The extent was recorded
semiquantitatively as the percentage of the cells that showed
positive staining, as follows: negative (o5% of the cells), focal (5–
49% of the cells) and diffuse (X50% of the cells). The intensity was
graded as negative (0), weak (1þ ) and moderate to strong (2þ to
3þ ). For p16, both cytoplasmic and/or nuclear staining was
recorded. Faint cytoplasmic staining (þ / ) was considered as a
nonspecific reaction.
HPV genotyping. The detection method employed a modified E6/
E7-specific consensus PCR, using mixed primers (pU-1M, pU-1M-
L/pU-2R and pU-2R-N). The PCR method used was a minor
modification of published procedures (Inoue et al, 1995; Yamazaki
et al, 2001), where modification of the primer sequences made it
possible to amplify 13 H-HPV types (HPV 16, 18, 31, 33, 35, 39,
45, 51, 52, 58, 67, 68 and 70). The PCR-based procedure was
performed by the Takara Bio Corporation (Otsu, Shiga, Japan).
The sequence of the PCR reactions was 94 oC for 30 s, 55 1C for 60 s
and 72 oC for 60 s, and each cycle was repeated 35 times.
Polymerase chain reaction product sizes ranged from 231 to 271
base pairs and represent the E6 and E7 regions of the H-HPV
types. Genotyping of H-HPV DNA was performed according to
the restriction fragment length polymorphism method described
by Lungu et al (1992). In situations where genotyping was not
detected by restriction enzyme analysis, it was determined by direct
sequencing of the amplified products.
RESULTS
There were 84 cases with known H-HPV data enrolled in the
Japanese cohort, and among these, 13 LEGHs were identified.
Among these 13 cases of LEGH, 6 had coexisting mucinous
adenocarcinoma: 3 were in situ and 3 were invasive. All three
invasive adenocarcinomas were extremely well differentiated and
exhibited histological features of mucinous GA as described by
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Kojima et al (2007). For comparative purposes, 12 cases of
H-HPV-positive CGLs, including AIS (n¼ 8) and adenocarcinoma
(n¼ 4), and 27 cases with benign cervix identified in the Japanese
cohort were also included in the study. The 27 benign cases were
used as the negative control group. The ages of the patients ranged
from 36 to 80 (median: 55 years) in all cases of LEGH with or
without AIS or GA, and from 32 to 56 (median: 45 years) in those
patients with CGLs. Characteristic histological features of LEGH,
described as well-demarcated proliferation of glands with a lobular
architecture, with the glands lined by tall, mucin-rich columnar
Figure 1. Histology of LEGH, LEGH with atypia, LEGH with coexisting AIS and mucinous GA and CA-IX expression in LEGH. Lobular endocervical
glandular hyperplasia without atypia (A) shows distinct lobular proliferation of the small- to medium-sized round glands surrounding larger central
cystic dilated glands. The glands are lined by tall, mucin-rich columnar cells with a basal arrangement of nuclei, similar to pyloric glands (A, inset).
Lobular endocervical glandular hyperplasia with atypia (C, D): some show nuclear enlargement, conspicuous nucleoli and apoptosis (C, arrow);
some exhibit papillary growth with nuclear irregularity and loss of polarity (D). Adenocarcinoma in situ is defined as when the gland was replaced
by cytologically malignant cells with associated apoptosis and/or mitosis (E). Adenocarcinoma with gastric phenotype exhibits voluminous clear
cytoplasm with stromal desmoplastic reaction (F). Note the small invasive gland embedded in the desmoplastic stroma (F, arrow). Carbonic
anhydrase-IX expression in the LEGH without atypia is limited to the central larger cystic glands (B, arrow). Original magnifications: 100 in (A)
and 400 (A, inset and B–F).
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cells with a basal arrangement of nuclei, were seen in all cases of
LEGH (Figure 1A). Out of 13 LEGHs, 12 exhibited variable degrees
of atypical features either focal or diffuse, including nuclear
enlargement, conspicuous nucleoli, loss of polarity, papillary
growth and mitosis/apoptosis (Figures 1C, D and 3A, D, G).
Among these, three had coexisting AIS (Figure 1E) and three had
coexisting GA (Figures 1F and 2D).
H-HPV infection. All cases of CGL, LEGH and LEGH with AIS
or GA/MDA were tested for H-HPV infection. The results are
summarised in Tables 1 and 2. High-risk human papillomavirus
DNA was detected in 83% (10 out of 12) of the CGLs (Table 1). All
but one contained a single genotype: 7 (3 AIS, 4 adenocarcinomas)
were type 18; 2 AIS were type 16; and 1 AIS contained both HPV18
and HPV16 DNA. High-risk human papillomavirus was not
detected in any cases of LEGH or LEGH with AIS or GA.
P16 and CA-IX expression. Carbonic anhydrase-IX immunor-
eactivity in the tissue sections was observed in 100% (12 out of 12)
of CGLs and p16 in 92% (11 out of 12). With the exception of one
poorly differentiated adenocarcinoma, the positive staining for
both CA-IX and p16 was intense (2þ to 3þ ) and diffuse
(Figure 2B and C). Carbonic anhydrase-IX expression was also
seen in all 13 cases of LEGH with or without AIS or GA. Carbonic
anhydrase-IX expression in those glands without typical features
was limited to central larger glands (Figure 1B). In contrast, in
those cases of LEGH with atypical features diffuse CA-IX
immunoreactivity was seen, not only limited to the central larger
glands but also in those glands with atypical cytological features
(Figure 3B and E) and the glands with papillary configuration
(Figure 3H). For those cases of AIS or GA with coexisting LEGH,
all malignant glands exhibited diffuse strong CA-IX immunor-
eactivity (Figure 2E). In contrast, only 62% (8 out of 13) of LEGH,
LEGHs with atypia and LEGHs with AIS or GA expressed p16, and
the immunoreactivity in all cases was either negative (Figure 2F) or
very weak cytoplasmic staining (Figure 3C, F and I). For the
negative control group, CA-IX expression was either negative or
limited to few reserve cells or columnar cells. Furthermore, the
intensity of staining was weak and cytoplasmic (Figure 2G). These
findings are consistent with our previous observation (Liao et al,
1994). Carbonic anhydrase-IX expression was also tested on
exfoliative cervical cells in PS from all cases of CGL, LEGH, LEGH
with atypia and LEGH with coexisting AIS or GA. With the
exception of one LEGH without atypia, diffuse strong immuno-
positive staining was seen in exfoliative endocervical glandular cells
in all cases (data not shown and Figure 2H and I).
DISCUSSION
It is widely accepted that H-HPV infection has a crucial role in the
aetiology of cervical carcinoma. Almost all cases of squamous cell
carcinomas and the vast majority of adenocarcinomas were
reported to contain H-HPV genotypes. However, in our recent
study, conducted on Japanese women with a cytological diagnosis
of AGC, H-HPV infection was identified in only 53% of cervical
adenocarcinomas (Liao et al, 2010). In this study, retrospective
review of the histology found that 13 of 15 H-HPV-negative cases
exhibited histological features of LEGH with or without the
coexisting AIS or GA. When these special subsets of glandular
A B C
D E F
G H I
Figure 2. Examples of CA-IX and p16 immunoreactivity in CGL, GA and CA-IX expression in normal cervix and exfoliated endocervical cells.
Strong membranous reaction for CA-IX (B) and cytoplasmic and nuclear staining for p16 (C) was seen in all cases of CGL, but the normal gland was
non-reactive for CA-IX or p16 (B and C, arrows). In contrast, in cases of GA only strongly positive CA-IX staining was seen (E), and p16 expression
was either weakly cytoplasmic or negative (F). In normal cervical glands, CA-IX expression was limited to a few columnar/reserve cells, and the
staining was weak and limited to the cytoplasm (G, arrow). Atypical glandular cells (H) derived from GA and normal looking glandular cells (I)
derived from LEGH with atypia showed diffuse strong membranous positivity for CA-IX. The relevant haematoxylin and eosin (H&E)-stained tissue
sections are shown in (A) and (D). Original magnifications:  200 in (D–F) and  400 in (A–C, G–I).
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Figure 3. Histology and immunohistochemical staining for CA-IX and p16 protein expression in LEGH with atypia. In contrast to Figure 1B,
CA-IX immunoreactivity was not only limited to the central larger glands but was also observed in the atypical glands (B, arrow, and E). Diffuse CA-
IX membranous positivity was also seen in LEGH with atypical papillary growth (H). Note that the small glands without atypia were CA-IX negative
(E, arrow). In contrast, p16 expression in all cases of LEGH with atypia was either negative or exhibited very weak cytoplasmic staining (C, Fand I).
The relevant haematoxylin and eosin (H&E)-stained tissue sections are shown in (A, D and G). Original magnification: 400.
Table 1. Detection of the expression of CA-IX and p16 proteins and
H-HPV DNA in CGLs
CA-IX p16 H-HPV
Pos (D/F) Pos (D/F) Pos (type)
12/12 11/12 10/12
Case no. Diagnosis (100%) (92%) (83%)
1 AIS 3þ (D) 3þ (D) Negative
2 AIS 3þ (D) 0 Negative
3 AIS 3þ (D) 3þ (D) Pos (16)
4 AIS 3þ (D) 3þ (D) Pos (16)
5 AIS 3þ (D) 3þ (D) Pos (18)
6 AIS 3þ (D) 3þ (D) Pos (18)
7 AIS 3þ (D) 3þ (D) Pos (18)
8 AIS 3þ (D) 3þ (D) Pos (16; 18)
9 Adenocarcinoma 3þ (D) 3þ (D) Pos (18)
10 Adenocarcinoma 3þ (D) 3þ (D) Pos (18)
11 Adenocarcinoma 3þ (D) 3þ (D) Pos (18)
12 Adenocarcinoma 3þ (F) 3þ (F) Pos (18)
Abbreviations: AIS¼ adenocarcinoma in situ; CA-IX¼ carbonic anhydrase-IX; CGL¼
conventional glandular lesion; H-HPV¼ high-risk human papillomavirus; Neg¼ negative;
Pos¼positive; D¼diffuse positive (X50% of cells); F¼ focal; (16;18)¼HPV type.
Table 2. Detection of expression of CA-IX and p16 proteins and H-HPV
DNA in cases of LEGH, and well-differentiated mucinous GA
CA-IX p16 H-HPV
Pos (D/F) Neg Pos (D/F)
Case no. Diagnosis 13/13 5/13 8/13 0/13
(100%)a (38%) (62%)a
1 LEGH 2þ (F) — None
2 LEGHþ atypia 2þ (D) — None
3 LEGHþ atypia 3þ (D) 1þ (F) None
4 LEGHþ atypia 3þ (F) 1þ (F) None
5 LEGHþ atypia 2þ (F) — None
6 LEGHþ atypia 3þ (D) 1þ (F) None
7 LEGHþ atypia 2þ (D) 1þ (F) None
8 LEGHþAIS 3þ (D) — None
9 LEGHþAIS 3þ (D) 1þ (F) None
10 LEGHþAIS 2þ (F) — None
11 LEGHþGA 2þ (D) 1þ (F) None
12 LEGHþGA 3þ (D) 1þ (F) None
13 LEGHþGA 3þ (D) 1þ (F) None
Abbreviations: AIS¼ adenocarcinoma in situ; CA-IX¼ carbonic anhydrase-IX; D¼diffuse
(positivity inX50% of cells); F¼ focal; GA, adenocarcinoma with gastric phenotype; H-HPV¼
high-risk human papillomavirus; LEGH¼ lobular endocervical glandular hyperplasia.
aThe immunoreactivity of p16-positive cases was weak (1þ ) and focal. In contrast, CA-IX
positivity was always intense (2þ , 3þ ).
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lesions are excluded, the prevalence of H-HPV DNA detection in
CGLs in this study was 83% (10 out of 12), which falls within the
range of 83–100% reported in the literature (Pirog et al, 2000). In
the case of the two H-HPV-negative AIS (see Table 1), one
exhibited gastric morphology without associated destructive
stromal reaction. This raises the possibility that this lesion may
represent in situ GA, although this has not been definitively
proven. Interestingly, this gastric-type like AIS was also p16
negative. The other HPV-negative case had histological features of
conventional AIS, but the lesion in this case was limited to two
glands. Thus, the negative result in this case may be due to
insufficient H-HPV DNA load. Furthermore, this explanation is
supported by the observation of diffuse expression of the p16
protein, a biomarker strongly correlated with H-HPV infection.
LEGH is a rare lesion of the uterine cervix that usually occurs in
postmenopausal women, with a reported incidence of 0.7%
(Mikami et al, 2001). In this study, we identified 13 out of 84
(15%) of LEGHs and, among these, 6 (46%) had coexisting AIS or
GA. The rate of LEGH and LEGH associated with AIS or GA in
our study is higher than that reported in the literature (Mikami
et al, 2001; Nara et al, 2007) and this discrepancy may be attributed
to our focus on the selection of cases where only women with a
cytological diagnosis of AGC were included. All 13 cases, and one
AIS without associated LEGH, reported here exhibited gastric
phenotype, which was further supported by positive immunostain-
ing of the lesions with anti-MUC-6 antibody, a marker of pyloric
glands (data not shown). None of these cases contained H-HPV
DNA or expressed high levels of p16 protein. As illustrated in
Figure 3, variable degrees of atypical features were observed in all
LEGHs but one, and the expression of CA-IX protein appears to be
closely related to the atypia. Our findings appear to support the
notion that LEGH and GA are closely related lesions and arise
independently of H-HPV infection. Similar H-HPV-negative
cervical lesions have been recently reported that also exhibit
special histological features described as LEGH, MDA, mucinous
GA, mesonephric and clear-cell carcinoma. Thus, it is possible that
separate and distinct molecular genetic events, independent of
H-HPV infection, may have a role in the progression to the
malignant condition in this category of cervical glandular lesions
compared with CGLs.
Our previous studies have shown the diagnostic utility of CA-IX
in detecting CGLs in patients with a cytological diagnosis of AGC.
In this study, we show that practically all of the exfoliative
endocervical glandular cells derived from the glandular cells of all
cases of LEGH with atypia, AIS and adenocarcinoma of usual type
or gastric phenotype showed diffuse and strong CA-IX immunor-
eactivity. Correspondingly, high levels of CA-IX expression were
also identified in the tissue sections of all cases tested in the study.
This novel finding has a significant clinical implication. It has been
reported that most cases of GA, including MDA, are diagnosed at
an advanced clinical stage and carry a poor prognosis (Gilks et al,
1989; Kojima et al, 2007). The vast majority of cases of GA was
H-HPV negative and showed the absence or low levels of p16
expression. Thus, CA-IX protein expression in both exfoliative cells
and tissue sections appears to serve as a useful biomarker for
diagnosing LEGH-related lesions or the gastric phenotype
neoplasms. Confirmation of this possibility awaits further analyses
with more cases. Significant CA-IX expression in LEGHs with
atypia and without associated carcinoma is an intriguing finding.
Molecular genetic analyses of these cases should enable resolution
of the speculation that LEGH may be a precursor of GA. Another
area that warrants special consideration is the identification of the
molecular genetic defects and aberrant signalling pathways that
exist in this category of cervical glandular lesions as compared with
the CGLs that are associated with H-HPV infection. High-risk
human papillomavirus E6 and E7 products effectively abrogate the
p53 and Rb tumour suppressor functions. Are these genes mutated
in LEGH and/or GA cells or are other pathways operating that
effectively bypass these powerful tumour suppressor functions?
In conclusion, our study has supported the following claims: (1)
H-HPV DNA, p16 and CA-IX protein expression are useful
biomarkers for detecting CGLs; (2) the subset of cervical lesions
that encompasses LEGH with coexisting AIS or GA arise
independently of H-HPV infection; (3) CA-IX may serve as the
optimal surrogate biomarker for identifying this subset of cervical
neoplasm with gastric phenotype; (4) the spectrum of histological
changes seen in LEGH, LEGH with atypia and LEGH with AIS or
GA suggests there is a possible link between LEGH and mucinous
GA; and (5) the high rate (46%) of LEGHs associated with AIS and
GA observed in this study warrants special attention being paid to
identify LEGH with atypia in those women with an AGC
cytological diagnosis.
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